Prostate Cancer
Co-designing an online treatment decision aid for men with low-risk prostate cancer: Navigate.
January 8, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
January 8, 2024
Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells - implications for systemic control.
January 8, 2024
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
January 5, 2024
First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.
January 4, 2024
Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision.
January 4, 2024